Author

S. Makino

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Organism:plant (other)· 1

Frequent Co-Authors

K. G. Lokugamage· 2 shared K. Narayanan· 2 shared M. Kuroda· 2 shared V. D. Menachery· 2 shared A. E. Muruato· 1 shared A. Gluck· 1 shared A. Nachshon· 1 shared A. Tamin· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

K. G. Lokugamage

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MicrobiologybioRxivMar 14, 2022

Parsing the role of NSP1 in SARS-CoV-2 infection

T. Fisher, A. Gluck, K. Narayanan…·N. Stern-Ginossar

This study investigates the role of SARS-CoV-2 nsp1 in host shutoff and immune evasion, finding it inhibits translation and induces mRNA degradation, and is critical for counteracting the IFN response.

DOI 10.1016/j.celrep.2022.110954

humanexperimental assay

𝕏 PostBluesky

MicrobiologyNature CommunicationsPeer-reviewedOct 15, 2020

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19

P.-Y. Shi, X. Xie, A. E. Muruato…·J. P. Bilello

This paper develops a high-throughput assay using a nanoluciferase-modified SARS-CoV-2 virus to rapidly test neutralizing antibodies and antiviral drugs.

DOI 10.1038/s41467-020-19055-7

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintMar 2, 2020

Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

J. Harcourt, A. Tamin, X. Lu…·N. J. Thornburg

The paper isolates and characterizes SARS-CoV-2 from the first US COVID-19 patient, showing high replication in Vero cells and depositing the strain for public use.

DOI 10.1101/2020.03.02.972935

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivJan 2, 2019

A novel defective recombinant porcine enterovirus G virus carrying a porcine torovirus papain-like cysteine protease gene and a putative anti-apoptosis gene in place of viral structural protein genes

R. Imai, M. Nagai, S. Sakaguchi…·T. Mizutani

The paper identifies a novel recombinant porcine EV-G virus with a porcine torovirus PLCP gene replacing viral structural genes, and suggests a potential helper virus role for type 1 recombinant EV-G.

DOI 10.1016/j.meegid.2019.103975

plant (other)experimental assay

𝕏 PostBluesky